Hemolysis in a Patient With Alkaptonuria and Chronic Kidney Failure

American Journal of Kidney Diseases

Volumn 56, Issue 1, 2010, Pages e1-

  Heng, Anne Elisabeth ^a   Courbebaisse, Marie ^a   Kemeny, Jean Louis ^b,c   Matesan, Raluca ^a   Bonniol, Claude ^a   Deteix, Patrice ^a,c   Souweine, Bertrand ^a,c  

^a Service de Néphrologie Réanimation Médicale   (France)

^b SERVICE DE RHUMATOLOGIE   (France)

^c UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

Alkaptonuria; hemolysis; homogentisic acid; ochronosis; renal failure

Indexed keywords

ACETYLCYSTEINE; ASCORBIC ACID; CARBAMAZEPINE; CREATININE; LAMOTRIGINE; LISINOPRIL; MELANIN;

ADULT; ALKAPTONURIA; ARTICLE; AUTOPSY; BLOOD ANALYSIS; BODY MASS; CASE REPORT; CHRONIC KIDNEY FAILURE; CREATININE BLOOD LEVEL; DRUG WITHDRAWAL; EPILEPSY; FAMILY HISTORY; GAS CHROMATOGRAPHY; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HEMOLYSIS; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; KIDNEY BIOPSY; KIDNEY FUNCTION; LABORATORY TEST; LEG SWELLING; MALE; METABOLIC ACIDOSIS; RENAL REPLACEMENT THERAPY; RETICULOCYTE COUNT; SKIN PIGMENTATION; URINALYSIS;

EID: 77953810112     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.11.023     Document Type: Article

References (12)

1. Phornphutkul C., Introne W.J., Perry M.B., et al. Natural history of alkaptonuria. N Engl J Med 347 26 (2002) 2111-2121
2. Venkataseshan V.S., Chandra B., Graziano V., et al. Alkaptonuria and renal failure: a case report and review of the literature. Mod Pathol 5 4 (1992) 464-471
3. Kazancioglu R., Taylan I., Aksak F., et al. Alkaptonuria and renal failure: a case report. J Nephrol 17 3 (2004) 441-445
4. Zatkova A., de Bernabe D.B., Polakova H., et al. High frequency of alkaptonuria in Slovakia. Evidence for the appearance of multiple mutations in HGO involving different mutational hot spots. Am J Hum Genet 67 5 (2000) 1333-1339
5. Ladjouze-Rezig A., Rodriguez de Cordoba S., and Aquaron R. Ochronotic rheumatism in Algeria: clinical, radiological, biological and molecular studies-a case study of 14 patients in 11 families. Joint Bone Spine 73 3 (2006) 284-292
6. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 1 (1976) 31-41
7. Introne W.J., Phornphutkul C., Bernardini I., McLaughlin K., Fitzpatrick D., and Gahl W.A. Exacerbation of the ochronosis of alkaptonuria due to renal insufficiency and improvement after renal transplantation. Mol Genet Metab 77 1-2 (2002) 136-142
8. Hegedus Z.L., and Nayak U. Homogentisic acid and structurally related compounds as intermediates in plasma soluble melanin formation and in tissue toxicities. Arch Int Physiol Biochim Biophys 102 3 (1994) 175-181
9. Hegedus Z.L. The probable involvement of soluble and deposited melanins, their intermediates and the reactive oxygen side-products in human diseases and aging. Toxicology 145 2-3 (2000) 85-101
10. Kuroda M., Asaka S., Tofuku Y., and Takeda R. Serum antioxidant activity in uremic patients. Nephron 41 3 (1985) 293-298
11. Forslind K., Wollheim F.A., Akesson B., and Rydholm U. Alkaptonuria and ochronosis in three siblings. Ascorbic acid treatment monitored by urinary HGA excretion. Clin Exp Rheumatol 6 3 (1988) 289-292
12. Suwannarat P., O'Brien K., Perry M.B., et al. Use of nitisinone in patients with alkaptonuria. Metabolism 54 6 (2005) 719-728